| Code | 25855 | ||||||||
| MA number | 12/0852/92-S | ||||||||
| Product Form: | sol inj 50x5 ml/100 mg (amp.skl.) | ||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||
| Type of procedure: | National | ||||||||
| MAH, country: | Vifor France, France | ||||||||
| Therapeutic Class: | 12 - ANTIANAEMICA | ||||||||
| ATC: |
|
||||||||
| Shelf life: | 36 | ||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 28.12.1992 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Dokument: |
DHPC železo iv 28 10 2013.pdf
|
| Dokument: |
DHPC železo Annex II_SK.pdf
|
| Dokument: |
DHPC železo Annex I_SK.pdf
|
| SPC: |
SPC_Venofer_03.2022.pdf
|
| PIL: |
PIL_Venofer_03.2022.pdf
|
| Safety feature | Yes |
| Data update: | 10.02.2020 |
